| References of collagen and chondrocyte research and assays: |
1996; 79(2):142, 2000; 27(3):575, Arthritis Rheum 1984;27:1370, Arthritis Rheum 1990;33:1493, Cho C, Clague RB, Clin Imm , Collagens with Autologous Type II Collagen, Cremer , DeArmey , Formation to Cartilage in Rheumatoid Arthritis: Possible Cross, Fujii K, Griffiths M, Hong Y, IgG and IgM antibody , IgG antibodies to type II collagen reflect inflammatory , Int Orthop 1992;16:272, Joo Y, Journal of Rheumatology, K, Kang Y, Katayama K, Kim , Kim , Kitamura A, Lee S, Lee S, Min J, Moore LJ, Murota K, Park , Park , Shimozuru Y, Specificity , Terato K, Terato K, The Mechanism of Autoantibody , The diagnostic , Tsuji M, Won Park, Ye X, Yoo W, et al, , , , , , , , , , , , , , , 154(13) , 6, 7, 500, 581, A, A, D, H, H, H, H, H, I, Immunopath, J, J, Kim , M, M, M, Reaction of Antibodies to Dietary , S, S, S, S, S, S, U, W, Y, activity , anticollagen immune complexes in synovial fluid, assay , in patients with rheumatoid arthritis, in rheumatoid arthritis, of antibodies to type II collagen in rheumatoid arthritis, significance of anti, to native type II collagen in rheumatoid serum and synovial fluid: evidence for the presence of collagen, type II collagen antibody |
| Description: |
Not all receptor antagonist that bind to enzymes are inhibitors, Since blocking an enzyme's activity can kill a pathogen , activator, caspase, esterase inhibitors , lipoprotein, many drugs are enzyme inhibitors, papain, pathway, peptidase, protease , proteinase, trypsin, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme, , Tissue, acrosin, activity, and decreases its , are , bind to enzymes and increase their , enzymatic activity, enzyme activator ligands or agonists , enzyme receptor , imbalance, metabolic , or correct a , or receptor ligands or receptor antagonists that bind to an , proteins |